Roche (OTCMKTS:RHHBY) Cut to “Sell” at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft cut shares of Roche (OTCMKTS:RHHBY) from a hold rating to a sell rating in a research note issued to investors on Friday morning, MarketBeat reports.

A number of other equities analysts have also weighed in on RHHBY. The Goldman Sachs Group began coverage on Roche in a research note on Thursday, May 30th. They set a sell rating on the stock. Bank of America raised Roche from a neutral rating to a buy rating in a research report on Friday. Three equities research analysts have rated the stock with a sell rating, one has given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, Roche currently has a consensus rating of Hold.

Roche Stock Performance

Shares of RHHBY opened at $39.11 on Friday. Roche has a 52-week low of $29.20 and a 52-week high of $42.43. The company has a quick ratio of 1.04, a current ratio of 1.35 and a debt-to-equity ratio of 0.75. The firm’s fifty day moving average is $39.59 and its two-hundred day moving average is $34.85.

Hedge Funds Weigh In On Roche

Several institutional investors have recently modified their holdings of RHHBY. HighPoint Advisor Group LLC acquired a new position in shares of Roche during the 4th quarter worth about $373,000. Associated Banc Corp grew its position in Roche by 13.8% during the 4th quarter. Associated Banc Corp now owns 48,484 shares of the company’s stock worth $1,761,000 after purchasing an additional 5,890 shares during the last quarter. Bard Financial Services Inc. increased its stake in Roche by 36.6% in the fourth quarter. Bard Financial Services Inc. now owns 19,800 shares of the company’s stock valued at $717,000 after purchasing an additional 5,300 shares during the period. OLD National Bancorp IN boosted its stake in shares of Roche by 3.2% during the second quarter. OLD National Bancorp IN now owns 265,242 shares of the company’s stock worth $9,206,000 after buying an additional 8,146 shares during the period. Finally, Hemenway Trust Co LLC grew its holdings in shares of Roche by 86.6% during the first quarter. Hemenway Trust Co LLC now owns 17,981 shares of the company’s stock worth $574,000 after buying an additional 8,345 shares during the last quarter.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.